Common asthma drug shows promise for reversing fatty liver

MedicalXpress | mai 08, 2026

MUSC researchers are tackling MASH, or metabolic dysfunction-associated steatohepatitis, a liver disease affecting hundreds of millions worldwide. It is also a leading cause of liver transplantation, yet treatment options remain limited.